Skip to main content
Erschienen in: PharmacoEconomics 2/2004

01.02.2004 | Current Opinion

The Generation Gap

Differences Between Children and Adults Pertinent to Economic Evaluations of Health Interventions

verfasst von: Ron Keren, Susmita Pati, Chris Feudtner

Erschienen in: PharmacoEconomics | Ausgabe 2/2004

Einloggen, um Zugang zu erhalten

Abstract

Differences between children and adults have both technical and ethical implications for the design, interpretation and employment of economic analyses of health-related programmes. Even though policy makers increasingly turn to economic analyses to inform decisions about resource allocation, pertinent child-adult differences have received fragmented discussion in leading methodological references.
Key areas warranting attention include: the ways in which a child’s distinctive biology modifies the cost and effectiveness of healthcare interventions; challenges in assessing utilities for infants and young children given their limited but developing cognitive capacity; how a child’s age, dependency and disability affect the selection of the appropriate time horizon and scope of the analysis; whether a child’s non-wage earning productivity should be incorporated into analyses, and if so, what metric to use; what principles of equity policy makers should employ in using economic evaluations to choose between child- and adult-focused interventions; and whether special protective measures should be introduced to secure the rights and interests of children who cannot advocate for themselves.
Literatur
1.
Zurück zum Zitat Halpern SA. American pediatrics: the social dynamics of professionalism, 1880–1980. Berkeley (CA): University California Press, 1988 Halpern SA. American pediatrics: the social dynamics of professionalism, 1880–1980. Berkeley (CA): University California Press, 1988
2.
Zurück zum Zitat Stern AM, Markel H. Formative years: children’s health in the United States: 1880–2000. Ann Arbor (MI): University of Michigan Press, 2002CrossRef Stern AM, Markel H. Formative years: children’s health in the United States: 1880–2000. Ann Arbor (MI): University of Michigan Press, 2002CrossRef
3.
Zurück zum Zitat Gold MR, Siegel JE, Russell LB, Weinstein MC. Cost-effectiveness in health and medicine. New York: Oxford University Press, 1996 Gold MR, Siegel JE, Russell LB, Weinstein MC. Cost-effectiveness in health and medicine. New York: Oxford University Press, 1996
4.
Zurück zum Zitat Graham JD, Goldie SJ, Segui-Gomez M, et al. Reducing risks to children in vehicles with passenger airbags. Pediatrics 1998; 102: e3 Graham JD, Goldie SJ, Segui-Gomez M, et al. Reducing risks to children in vehicles with passenger airbags. Pediatrics 1998; 102: e3
5.
Zurück zum Zitat Graham JD, Thompson KM, Goldie SJ, et al. The cost-effectiveness of air bags by seating position. JAMA 1997; 278: 1418–25CrossRef Graham JD, Thompson KM, Goldie SJ, et al. The cost-effectiveness of air bags by seating position. JAMA 1997; 278: 1418–25CrossRef
6.
Zurück zum Zitat Czeizel AE, Dudas I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation [comment]. New Engl J Med 1992; 327: 1832–5CrossRef Czeizel AE, Dudas I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation [comment]. New Engl J Med 1992; 327: 1832–5CrossRef
7.
Zurück zum Zitat Milunsky A, Jick H, Jick SS, et al. Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects [comment]. JAMA 1989; 262: 2847–52CrossRef Milunsky A, Jick H, Jick SS, et al. Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects [comment]. JAMA 1989; 262: 2847–52CrossRef
8.
Zurück zum Zitat Wald DS, Law M, Moms JK. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ 2002;325:1202CrossRef Wald DS, Law M, Moms JK. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ 2002;325:1202CrossRef
9.
Zurück zum Zitat Romano PS, Waitzman NJ, Scheffler RM, et al. Folic acid fortification of grain: an economic analysis. Am J Public Health 1995; 85: 667–76CrossRef Romano PS, Waitzman NJ, Scheffler RM, et al. Folic acid fortification of grain: an economic analysis. Am J Public Health 1995; 85: 667–76CrossRef
10.
Zurück zum Zitat Jenney ME, Campbell S. Measuring quality of life. Arch Dis Child 1997; 77: 347–50CrossRef Jenney ME, Campbell S. Measuring quality of life. Arch Dis Child 1997; 77: 347–50CrossRef
11.
Zurück zum Zitat Juniper EF, Guyatt GH, Feeny DH, et al. Minimum skills required by children to complete health-related quality of life instruments for asthma: comparison of measurement properties. Fur Respir l 1997; 10: 2285–94CrossRef Juniper EF, Guyatt GH, Feeny DH, et al. Minimum skills required by children to complete health-related quality of life instruments for asthma: comparison of measurement properties. Fur Respir l 1997; 10: 2285–94CrossRef
12.
Zurück zum Zitat Guyatt GH, Juniper EF, Griffith LE, et al. Children and adult perceptions of childhood asthma. Pediatrics 1997; 99: 165–8CrossRef Guyatt GH, Juniper EF, Griffith LE, et al. Children and adult perceptions of childhood asthma. Pediatrics 1997; 99: 165–8CrossRef
13.
Zurück zum Zitat Yi MS, Britto MT, Wilmott RW, et al. Health values of adolescents with cystic fibrosis. J Pediatr 2003; 142: 133–40CrossRef Yi MS, Britto MT, Wilmott RW, et al. Health values of adolescents with cystic fibrosis. J Pediatr 2003; 142: 133–40CrossRef
14.
Zurück zum Zitat Saigal S, Stoskopf BL, Feeny D, et al. Differences in preferences for neonatal outcomes among health care professionals, parents, and adolescents. JAMA 1999; 281: 1991–7CrossRef Saigal S, Stoskopf BL, Feeny D, et al. Differences in preferences for neonatal outcomes among health care professionals, parents, and adolescents. JAMA 1999; 281: 1991–7CrossRef
15.
Zurück zum Zitat Torrance GW, Furlong W, Feeny D, et al. Multi-attribute preference functions: Health Utilities Index. Pharmacoeconomics 1995; 7 (6: 503–20CrossRef Torrance GW, Furlong W, Feeny D, et al. Multi-attribute preference functions: Health Utilities Index. Pharmacoeconomics 1995; 7 (6: 503–20CrossRef
16.
Zurück zum Zitat Feeny D, Furlong W, Boyle M, et al. Multi-attribute health status classification systems: Health Utilities Index. Pharmacoeconomics 1995; 7 (6: 490–502CrossRef Feeny D, Furlong W, Boyle M, et al. Multi-attribute health status classification systems: Health Utilities Index. Pharmacoeconomics 1995; 7 (6: 490–502CrossRef
17.
Zurück zum Zitat EuroQol: a new facility for the measurement of health-related quality of life: The EuroQol Group. Health Policy 1990; 16: 199–208CrossRef EuroQol: a new facility for the measurement of health-related quality of life: The EuroQol Group. Health Policy 1990; 16: 199–208CrossRef
18.
Zurück zum Zitat Stolk EA, Busschbach JJ, Vogels T. Performance of the EuroQol in children with imperforate anus. Qual Life Res 2000; 9: 29–38CrossRef Stolk EA, Busschbach JJ, Vogels T. Performance of the EuroQol in children with imperforate anus. Qual Life Res 2000; 9: 29–38CrossRef
19.
Zurück zum Zitat Kaplan RM, Anderson JP. A general health policy model: update and applications. Health Serv Res 1988; 23: 203–35PubMedPubMedCentral Kaplan RM, Anderson JP. A general health policy model: update and applications. Health Serv Res 1988; 23: 203–35PubMedPubMedCentral
20.
Zurück zum Zitat Lieu TA, Cochi SL, Black SB, et al. Cost-effectiveness of a routine varicella vaccination program for US children. JAMA 1994; 271: 375–81CrossRef Lieu TA, Cochi SL, Black SB, et al. Cost-effectiveness of a routine varicella vaccination program for US children. JAMA 1994; 271: 375–81CrossRef
21.
Zurück zum Zitat Keren R, Helfand M, Homer C, et al. Projected cost-effectiveness of statewide universal newborn hearing screening. Pediatrics 2002; 110: 855–64CrossRef Keren R, Helfand M, Homer C, et al. Projected cost-effectiveness of statewide universal newborn hearing screening. Pediatrics 2002; 110: 855–64CrossRef
22.
Zurück zum Zitat Barringer D, Mauk G. Survey of parents perceptions regarding hospital-based newborn hearing screening. Audiology Today 1997; 9: 18–9 Barringer D, Mauk G. Survey of parents perceptions regarding hospital-based newborn hearing screening. Audiology Today 1997; 9: 18–9
23.
Zurück zum Zitat Clemens CJ, Davis SA, Bailey AR. The false-positive in universal newborn hearing screening. Pediatrics 2000; 106: E7CrossRef Clemens CJ, Davis SA, Bailey AR. The false-positive in universal newborn hearing screening. Pediatrics 2000; 106: E7CrossRef
24.
Zurück zum Zitat Margolis HS, Coleman PJ, Brown RE, et al. Prevention of hepatitis B virus transmission by immunization: an economic analysis of current recommendations. JAMA 1995; 274: 1201–8CrossRef Margolis HS, Coleman PJ, Brown RE, et al. Prevention of hepatitis B virus transmission by immunization: an economic analysis of current recommendations. JAMA 1995; 274: 1201–8CrossRef
25.
Zurück zum Zitat Pedersen S, Warner J, Wahn U, et al. Growth, systemic safety, and efficacy during 1 year of asthma treatment with different beclomethasone dipropionate formulations: an open-label, ran domized comparison of extrafine and conventional aerosols in children. Pediatrics 2002; 109: e92 Pedersen S, Warner J, Wahn U, et al. Growth, systemic safety, and efficacy during 1 year of asthma treatment with different beclomethasone dipropionate formulations: an open-label, ran domized comparison of extrafine and conventional aerosols in children. Pediatrics 2002; 109: e92
26.
Zurück zum Zitat Allen DB. Inhaled corticosteroid therapy for asthma in preschool children: growth issues. Pediatrics 2002; 109: 373–80PubMed Allen DB. Inhaled corticosteroid therapy for asthma in preschool children: growth issues. Pediatrics 2002; 109: 373–80PubMed
27.
Zurück zum Zitat de Benedictis FM, Teper A, Green RJ, et al. Effects of 2 inhaled corticosteroids on growth: results of a randomized controlled trial. Arch Pediatr Adolesc Med 2001; 155: 1248–54CrossRef de Benedictis FM, Teper A, Green RJ, et al. Effects of 2 inhaled corticosteroids on growth: results of a randomized controlled trial. Arch Pediatr Adolesc Med 2001; 155: 1248–54CrossRef
28.
Zurück zum Zitat Harris J. QALYfying the value of life. J Med Ethics 1987; 13: 117–23CrossRef Harris J. QALYfying the value of life. J Med Ethics 1987; 13: 117–23CrossRef
29.
Zurück zum Zitat Singer P, McKie J, Kuhse H, et al. Double jeopardy and the use of QALYs in health care allocation. J Med Ethics 1995; 21: 144–50CrossRef Singer P, McKie J, Kuhse H, et al. Double jeopardy and the use of QALYs in health care allocation. J Med Ethics 1995; 21: 144–50CrossRef
30.
Zurück zum Zitat Cretin S. Cost/benefit analysis of treatment and prevention of myocardial infarction. Health Serv Res 1977; 12: 174–89PubMedPubMedCentral Cretin S. Cost/benefit analysis of treatment and prevention of myocardial infarction. Health Serv Res 1977; 12: 174–89PubMedPubMedCentral
31.
Zurück zum Zitat Boyle MIL Torrance GW, Sinclair JC, et al. Economic evaluation of neonatal intensive care of very-low-birth-weight infants. N Engl J Med 1983; 308: 1330–7CrossRef Boyle MIL Torrance GW, Sinclair JC, et al. Economic evaluation of neonatal intensive care of very-low-birth-weight infants. N Engl J Med 1983; 308: 1330–7CrossRef
32.
Zurück zum Zitat Williams A. Intergenerational equity: an exploration of the ‘fair innings’ argument. Health Econ 1997; 6: 117–32CrossRef Williams A. Intergenerational equity: an exploration of the ‘fair innings’ argument. Health Econ 1997; 6: 117–32CrossRef
33.
Zurück zum Zitat Patrick DL, Erickson P. Health status and health policy: quality of life in health care evaluation and resources allocation. New York: Oxford University Press, 1993 Patrick DL, Erickson P. Health status and health policy: quality of life in health care evaluation and resources allocation. New York: Oxford University Press, 1993
34.
Zurück zum Zitat Proctor BD, Dalaker J. Poverty in the United States: 2001: current population reports. Washington, DC: Census Bureau, 2002: P60–219 Proctor BD, Dalaker J. Poverty in the United States: 2001: current population reports. Washington, DC: Census Bureau, 2002: P60–219
35.
Zurück zum Zitat Benjamin AE, Newacheck PW, Wolfe H. Intergenerational equity and public spending. Pediatrics 1991; 88: 75–83PubMed Benjamin AE, Newacheck PW, Wolfe H. Intergenerational equity and public spending. Pediatrics 1991; 88: 75–83PubMed
36.
Zurück zum Zitat Detsky AS, Naglie IG. A clinician’s guide to cost-effectiveness analysis. Ann Intern Med 1990; 113: 147–54CrossRef Detsky AS, Naglie IG. A clinician’s guide to cost-effectiveness analysis. Ann Intern Med 1990; 113: 147–54CrossRef
37.
Zurück zum Zitat Ubel PA, DeKay ML, Baron J, et al. Cost-effectiveness analysis in a setting of budget constraints: is it equitable? N Engl J Med 1996; 334: 1174–7CrossRef Ubel PA, DeKay ML, Baron J, et al. Cost-effectiveness analysis in a setting of budget constraints: is it equitable? N Engl J Med 1996; 334: 1174–7CrossRef
38.
Zurück zum Zitat Ubel PA, Baron J, Nash B, et al. Are preferences for equity over efficiency in health care allocation all or nothing’? Med Care 2000; 38: 366–73CrossRef Ubel PA, Baron J, Nash B, et al. Are preferences for equity over efficiency in health care allocation all or nothing’? Med Care 2000; 38: 366–73CrossRef
39.
Zurück zum Zitat Ubel PA, Baron J, Asch DA. Preference for equity as a framing effect. Med Decis Making 2001; 21: 180–9CrossRef Ubel PA, Baron J, Asch DA. Preference for equity as a framing effect. Med Decis Making 2001; 21: 180–9CrossRef
Metadaten
Titel
The Generation Gap
Differences Between Children and Adults Pertinent to Economic Evaluations of Health Interventions
verfasst von
Ron Keren
Susmita Pati
Chris Feudtner
Publikationsdatum
01.02.2004
Verlag
Springer International Publishing
Erschienen in
PharmacoEconomics / Ausgabe 2/2004
Print ISSN: 1170-7690
Elektronische ISSN: 1179-2027
DOI
https://doi.org/10.2165/00019053-200422020-00001

Weitere Artikel der Ausgabe 2/2004

PharmacoEconomics 2/2004 Zur Ausgabe

Original Research Article

Cost of Stress Urinary Incontinence

Adis Pharmacoeconomic Drug Evaluation

Infliximab